GoodRx

Selected news for GoodRx, representing 1% of data collected since 10/2017. Recent stories appear in blogspot.com. This company shares news with Doug Hirsch, Digital Health, Morgan Stanley, Goldman Sachs, HeyDoctor and over a hundred others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
1/12/2021 What Could A Healthcare Marketplace Look Like? GoodRx Is Trying To Show Us Forbes ... price and convenience. The company earns revenue only only when it saves people money. Thus far, the company estimates it has helped Americans realize $20 billion in savings.Doing good is going well for GoodRx and its investors, as suggested by the company’s $18 billion market capitalization (as of the publish date).While GoodRx’s growth has been impressive, it also begs questions:How does GoodRx save people money ...
1/10/2021 Reviewing Clarivate (NYSE:CCC) and GoodRx (NASDAQ:GDRX) The Markets Daily N/AInsider and Institutional Ownership42.8% of Clarivate shares are owned by institutional investors. Comparatively, 13.2% of GoodRx shares are owned by institutional investors. 2.3% of Clarivate shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.SummaryClarivate beats GoodRx on 6 of the 10 factors compared between the ...
1/10/2021 Comparing Clarivate (NYSE:CCC) and GoodRx (NASDAQ:GDRX) wkrb13.com Clarivate ( NYSE:CCC ) and GoodRx ( NASDAQ:GDRX ) are both large-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation.Earnings and ValuationGet Clarivate alerts: This table compares Clarivate and GoodRx’s revenue, earnings per share and valuation.Gross Revenue Price/Sales Ratio Net Income Earnings ...
1/7/2021 GoodRx (NASDAQ:GDRX) and Clarivate (NYSE:CCC) Head to Head Analysis American Banking News GoodRx has lower revenue, but higher earnings than Clarivate.SummaryClarivate beats GoodRx on 6 of the 10 factors compared between the two stocks.Clarivate Company ProfileClarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne ...
1/5/2021 Retire Better: How seniors are already falling behind in 202 MarketWatch ... in 2021.Advocates said it wouldn’t be enough to keep up with the true cost of living , and just days into the new year, it looks like they were right.An analysis from GoodRx , a medical and health care services provider, calculates that 589 drugs—all but seven brand medications—now cost 4.2% more on average. That’s nearly three full percentage points more than the cost of living ...
1/4/2021 Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes FiercePharma ... the level of many of the price hikes seems muted compared with previous years.As of Sunday, drug companies large and small had raised prices on nearly 600 medicines by an average of 4.2%, GoodRx reports .Pfizer's hikes comprise a significant portion of the list: The company raised prices on more than 130 products to start the year, ranging from a 0.22% jump for antiarrhythmic medicine Norpace CR to a ...
1/1/2021 Could Medicare Help You Save on Expensive Asthma Inhalers? MSN ... Box / Shutterstock.com Skyrocketing inhaler costs pose a financial barrier for many of the 25 million Americans with asthma . The average cash price inhalers increased from $280 in 2013 to $380 in 2018, according to GoodRx .Load ErrorIf you need an inhaler and are on Medicare, the federal health insurance program for seniors and people with certain disabilities , a little-known option may help you reduce your medication costs — ...
12/29/2020 A look back at the how tech changed the pharma landscape in 2020 MobiHealthNews ... 19 emergency. During this period we saw both Pear Therapeutics and Akili Interactive Labs take advantage of this early release. Another major area of interest this year was digital pharmacies. This year we saw GoodRx and Hims go public, signaling more consumer interest in the space. Read on for a list of highlights of digital pharma initiatives: Forging partnerships Kicking off the 2020 year, in Europe pharma giant Bayer inked ...
12/29/2020 GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 gurufocus.com Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: [url="]www.bgandg.com ...
12/29/2020 GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 financialbuzz.com Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s ...
12/25/2020 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, and Encourages Investors to Contact the Firm Before February 16, 2021 financialbuzz.com The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply to the ...
12/24/2020 malvern-online.com The law firm of Kirby McInerney LLP announces that a has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply to the Court to be ...
12/24/2020 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm Before February 16, 2021 Business Wire NEW YORK- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply ...
12/24/2020 The Ridgway Record ridgwayrecord.com The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply to the ...
12/24/2020 Google Alert - marketing blogspot.com marketing As-it-happens update ⋅ December 24, 2020 NEWS Pet Palette Hires New Marketing Manager PetProductNews.com Limbeck has more than 10 years of marketing experience and is skilled at building a presence within the pet industry through strong branding, ... Flag as irrelevant WEB GoodRx - Inside Sales, Marketing Solution Lever Sales & Marketing – Operations /. Full Time. Apply for this job. At GoodRx , we believe that all Americans should have access ...
12/24/2020 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm Before February 16, 2021 gurufocus.com The law firm of [url="]Kirby+McInerney+LLP[/url] announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: [url="]GDRX[/url]) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 ...
12/24/2020 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action GDRX financialbuzz.com Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 to November 16, 2020, inclusive (the “Class Period”) of the important February 16, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.To join the GoodRx class action, go to http://www.rosenlegal.com/cases ...
12/23/2020 Is GoodRx Stock A Buy? financhill.com Is GoodRx Stock A Buy? - Financhill Menu Investing Is GoodRx Stock A Buy?Is GoodRx Stock A Buy? Telemedicine’s rising popularity has been spurred by the global pandemic. Talk about a sizzling investment space! For instance, consider Teladoc ( TDOC ) – the company’s stock has skyrocketed by almost 170% in 2020.While patients and their physicians adapt to a virtual world of interactions, the healthcare industry is desperately seeking ...
12/23/2020 The Ridgway Record ridgwayrecord.com NEW YORK, Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") ( NASDAQ: GDRX ) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm ...
12/23/2020 Is GoodRx Stock A Buy? blogspot.com Is GoodRx Stock A Buy? Telemedicine's rising popularity has been spurred by the global pandemic. Talk about a sizzling investment space! For instance, consider Market News Smart Trading. Simplified. Is this Killer new EXTRA INCOME strategy the Best Side Hustle EVER? Have you seen this new extra-income hack yet?Everyday Americans have been making 100%, 200%, 500%, or more... sometimes in a matter of days with this one new ...